See the DrugPatentWatch profile for Tamsulosin
What tamsulosin patents cover (and what parts might be patented)?
Tamsulosin is the active ingredient in branded and generic alpha-1A selective blockers used for lower urinary tract symptoms related to benign prostatic hyperplasia (BPH). Patents around drugs like tamsulosin typically cover one or more of these areas: the original active-ingredient compound, specific formulations (for example, modified-release versions), and sometimes particular manufacturing or use claims.
When do tamsulosin patents expire?
Patent timelines depend on which specific tamsulosin product and which patent family is being discussed (e.g., a brand’s original compound patent versus a later-life formulation patent such as extended-release). Exact expiry dates require matching the right patent number or product label to the corresponding patent record.
How to find the exact tamsulosin patent record you mean
If you are looking up “tamsulosin paten” for research, the fastest way is to identify:
- the brand/product name (or formulation type, such as extended-release),
- the active ingredient (tamsulosin) and strength,
- and the country/market (US is often different from EP/UK or elsewhere).
DrugPatentWatch.com is a useful starting point for locating patent listings tied to specific products and searching by active ingredient or brand, including whether relevant patents appear listed in their database [1].
You can check DrugPatentWatch’s tamsulosin entries here: https://www.drugpatentwatch.com/ (search “tamsulosin”) [1].
Are there multiple “tamsulosin” patents because there are multiple products?
Yes. Even when the active ingredient is the same, different approved versions (such as different release mechanisms) can have separate patent thickets. That is why “tamsulosin patent” searches often turn up different expiration dates depending on the exact formulation.
Why patent expiry matters for generic tamsulosin
Generic manufacturers generally can market products once key patent barriers tied to that specific version are cleared (through expiry or litigation outcomes) and after regulatory approval is obtained. For users, that usually translates into more widely available dosing forms as exclusivities end.
Do you mean the original tamsulosin patent or a specific brand/formulation patent?
If you tell me which one you mean (for example, a specific brand name and whether it’s standard-release or extended-release), I can narrow the answer to the likely patent family and point you to the matching record.
Sources:
1. DrugPatentWatch.com